Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GE vs MRNA✓SelectedUSD · MRNAGE vs MRNA performance historyLatest closeAs of-2.81%11/19
Stock and ETF performance explorer

GE vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+6.6%
MRNA return
+698.9%
Excess return
-692.3%
Maximum drawdown
-25.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-2.8%+1.3%-4.1%-2.8%
7D-3.6%-13.8%+10.2%-3.7%
30D+6.3%-17.7%+24.0%+6.3%
3M-10.3%+14.3%-24.7%-10.2%
6M+12.1%+336.0%-323.9%+9.2%
YTD+4.0%+575.9%-572.0%-4.8%
1Y+6.6%+724.4%-717.8%-4.8%
All+6.6%+698.9%-692.3%-4.8%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling